Condition
Avian influenza and seasonal influenza
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
5 treatments under study, led by Vaxigriptetra Injektioneste Suspensio Esitäytetty Ruisku Nelivalenttinen Influenssarokote Virusfragmentit Inaktivoitu
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Vaxigriptetra Injektioneste Suspensio Esitäytetty Ruisku Nelivalenttinen Influenssarokote Virusfragmentit Inaktivoitu1
- Fluad Suspension For Injection In Prefilled Syringeinfluenza Vaccine Surface Antigen Inactivated Adjuvanted1
- Vaxigrip Injektioneste Suspensio Esitäytetty Ruiskukolmivalenttinen Influenssarokote Virusfragmentit Inaktivoitu1
- Fluad Tetra Suspension For Injection In Prefilled Syringe Influenza Vaccine Surface Antigen Inactivated Adjuvanted1
- Zoonotic Influenza Vaccine Seqirus Suspension For Injection In Prefilled Syringezoonotic Influenza Vaccine H5n8 Surface Antigen Inactivated Adjuvanted1
Active Sponsors
- Finnish Institute for Health and Welfare1